Onyx Biotec P/E Ratio
Onyx Biotec P/E ratio. Onyx Biotec (ONYX) P/E ratio is not applicable — EPS (TTM) ₹-0.12. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-0.12
Healthcare Peers with Valid P/E Ratios — ONYX Comparison
Healthcare sector average P/E 54.76, median 31.4 — ONYX excluded (negative EPS).
Sector Average PE
54.76
Sector Median PE
31.4
Lowest PE
2.02
Profitable Companies
201
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.02 | ₹60 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.33 | ₹55 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.86 | ₹6,006 | Low |
| Dipna Pharmachem | DPL | 3.97 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 5.05 | ₹65 | Low |
| Royal Sense | ROYAL | 5.39 | ₹40 | Low |
| Kabra Drugs | KABRADG | 5.47 | ₹41 | Low |
| GKB Ophthalmics | GKB | 5.85 | ₹32 | Low |
| Colinz Laboratories | COLINZ | 6.31 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Onyx Biotec share price screener.
- Check ONYX market cap trends to track the company's total market size over time.
- Also explore Onyx Biotec share price performance to track price trends across different timeframes.